Elevated levels of Factor XI are associated with cardiovascular disease in women

Thrombosis Research

Volumn 107, Issue 1-2, 2002, Pages 55-60

  Berliner, Jennifer I ^a   Rybicki, Anne C ^a   Kaplan, Robert C ^a   Monrad, E ^a   Freeman, Ruth ^a   Billett, Henny H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Factor XI; Thrombophilia

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 11; CHOLESTEROL; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; FIBRINOGEN; HOMOCYSTEINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

AGE; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; THROMBOSIS; ADULT; ARTERY THROMBOSIS; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; HEART CATHETERIZATION; HUMAN CELL; HYPERTENSION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; THROMBOCYTE COUNT; VEIN THROMBOSIS;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; FACTOR XI; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS;

EID: 0037101594     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00190-1     Document Type: Article

References (29)

1. Wenger N.K., Speroff L., Packard B. Cardiovascular health and disease in women. N. Engl. J. Med. 329:1993;247-253.
2. Simmonds R.E., Hermida J., Rezende S.M., Lane D.A. Haemostatic genetic risk factors in arterial thrombosis. Thromb. Haemost. 86:2001;374-385.
3. Reiner A.P., Siscovick D.S., Rosendaal F.R. Hemostatic risk factors and arterial thrombotic disease. Thromb. Haemost. 85:2001;584-595.
4. Kamphuisen P.W., Eikenboom J.C., Bertina R.M. Elevated factor VIII levels and the risk of thrombosis. Arterioscler. Thromb. Vasc. Biol. 21:2001;731-738.
5. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risk in communities study. Circulation. 96:1997;1102-1108.
6. Carter A.M. Gender-specific associations of the fibrinogen B448 polymorphism, fibrinogen levels and acute cerebrovascular disease. Arterioscler. Thromb. Vasc. Biol. 17:1997;589-594.
7. Rosendaal F.R., Siscovick D.S., Schwartz S.M., Beverly R.K., Psaty B.M., Longstreth W.T.et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood. 89:1997;2817-2821.
8. Ripoll L., Paulin D., Thomas S., Drouet L.O. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of Factor V Leiden and G20210A transition of the prothrombin gene. Thromb. Haemost. 78:1997;960.
9. 448. Blood. 82:1993;2117-2124.
10. Braunstein J.B., Kershner D.W., Bray P., Gerstenblith G., Shulman S.P., Post W.S.et al. Interaction of hemostatic genetics with hormone therapy. Chest. 121:2002;906-920.
11. Meade T.W., Mellows S., Brozovic M., Miller G.J., Chakrabarti R.R., North W.R.et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet. 2:1986;533-537.
12. Heinrich J., Balleisen L., Schulte H., Assmann Gm van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Arterioscler. Thromb. 14:1994;54-59.
13. Meijers J.C.M., Tekelenburg W.L.H., Bouma B.N., Bertina R.M., Rosendaal F.R. High levels of coagulation factor XI as a risk factor for venous thrombosis. N. Engl. J. Med. 342:2000;696-701.
14. Merlo C., Wuillemin W.A., Redondo M., Furlan M., Sulzer I., Kremer-Hovinga J.et al. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis. 161:2002;261-267.
15. Giannitsis E., Siemens H.J., Mitusch R., Tettenborn I., Wiegand U., Schmucker G.et al. Prothrombin fragments F11, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis. Int. J. Cardiol. 68:1999;269-274.
16. Maresca G., DiBlasio A., Marchioli R., DiMinno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler. Thromb. Vasc. Biol. 19:1999;1368-1377.
17. Junker R., Heinrich J., Schulte H., van de Loo J., Assman G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler. Thromb. Vasc. Biol. 17:1997;1539-1544.
18. Smith F.B., Lee A.J., Fowkes F.G., Price J.F., Rumley A., Lowe G.D. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study. Arterioscler. Thromb. Vasc. Biol. 17:1997;3321-3325.
19. Redondo M., Watzke H.H., Sucki B., Sulzer I., Biassiutti F.D., Binder B.R.et al. Coagulation Factors II, V, VII and X, Prothrombin Gene 20210G to A transition, and Factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 19:1999;1020-1025.
20. Noto D., Barbagallo C.M., Cefalu A.B., Cavera G., Sapienza M., Norarbartolo A.et al. Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11 year follow up. Thromb. Haemost. 87:2002;206-210.
21. Ossei-Gerning N., Wilson I.J., Grand P.J. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb. Haemost. 79:1998;736-740.
22. Saito I., Folsom A.R., Brancati F.L., Duncan B.B., Chambless L.E., McGovern P.G. Non-traditional risk factors for coronary heart disease incidence among persons with diabetes: the atherosclerosis risk in communities (ARIC) study. Ann. Intern. Med. 133:2000;81-91.
23. Conlan M.G., Folsom A.R., Finch A., Davis C.E., Sorlie P., Marcucci G.et al. Associations of factor VIII and von Willebrand Factor with age, race, sex, and risk factors for atherosclerosis: the atherosclerosis risk in communities (ARIC) study. Thromb. Haemost. 70:1993;380-385.
24. Duncan B.B., Schmidt M.I., Offenbacher S., Wu K.K., Savage P.J., Heiss G. Factor VIII and other hemostasis variables are related to incident diabetes in adults. The atherosclerosis risk in communities (ARIC) study. Diabetes Care. 22:1999;767-772.
25. Rosove M.H., Brewer P.M. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann. Intern. Med. 17:1992;303-308.
26. Hamsten A., Norbert R., Bjorkholm M., de Faire U., Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1:1986;113-116.
27. De Caterina R., d'Ascanio A., Mazzone A., Gazzetti P., Bernini W., Neri R.et al. Prevalence of anticardiolipin antibodies in coronary artery disease. Am. J. Cardiol. 65:1990;922-923.
28. Yilmaz E., Adalet K., Yilmaz G., Badur S., Erzengin F., Koylan N.et al. Importance of serum anticardiolipin antibody levels in coronary heart disease. Clin. Cardiol. 17:1994;117-121.
29. Ahmed E., Stegmayr B., Trifunovic J., Weinehall L., Hallmans G., Lefvert A.K. Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke. 31:2000;1289-1293.